Pendal Group Ltd - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Pendal Group Ltd ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2022$78,758,102
-5.8%
465,171
+4.1%
0.68%
-16.5%
Q3 2022$83,613,000
+28633.0%
446,863
+40523.9%
0.81%
+40600.0%
Q4 2021$291,000
-31.9%
1,100
-50.6%
0.00%
-50.0%
Q4 2020$427,0002,2270.00%
Other shareholders
REPLIGEN CORP shareholders Q1 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders